Share the Tech If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
MSF Access Campaign Research by @MSF shows that one #COVID19 test could be sold at profit for US$5.So why is Cepheid charging 4X that price in developing countries?@CepheidNews must refrain from profiteering off of this pandemic and drop the price of this essential test. bit.ly/3gfPmAY 02:02 - 28 Jul 2020